F. Nantel

3.4k total citations
77 papers, 2.7k citations indexed

About

F. Nantel is a scholar working on Rheumatology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, F. Nantel has authored 77 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Rheumatology, 24 papers in Molecular Biology and 21 papers in Cellular and Molecular Neuroscience. Recurrent topics in F. Nantel's work include Rheumatoid Arthritis Research and Therapies (24 papers), Receptor Mechanisms and Signaling (20 papers) and Neuropeptides and Animal Physiology (18 papers). F. Nantel is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (24 papers), Receptor Mechanisms and Signaling (20 papers) and Neuropeptides and Animal Physiology (18 papers). F. Nantel collaborates with scholars based in Canada, United States and France. F. Nantel's co-authors include Kathleen M. Metters, Danielle Denis, D. Regoli, Michel Bouvier, N. Rouissi, Paolo Sassone‐Corsi, Nicholas S. Foulkes, Lucia Monaco, Kenth Henriksén and Marianne LeMeur and has published in prestigious journals such as Nature, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

F. Nantel

75 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Nantel Canada 27 1.2k 673 592 453 350 77 2.7k
Motonao Nakamura Japan 28 1.9k 1.6× 672 1.0× 757 1.3× 246 0.5× 667 1.9× 73 3.6k
Takanobu Taniguchi Japan 33 1.5k 1.3× 473 0.7× 324 0.5× 277 0.6× 302 0.9× 105 3.1k
Kiyoshi Furuichi Japan 28 1.9k 1.6× 518 0.8× 468 0.8× 156 0.3× 542 1.5× 52 3.5k
David F. Woodward United States 39 1.2k 1.0× 934 1.4× 552 0.9× 1.7k 3.9× 439 1.3× 149 4.9k
Pascal Peraldi France 28 2.8k 2.4× 1.8k 2.7× 287 0.5× 211 0.5× 548 1.6× 51 5.8k
Vasileia Ismini Alexaki Germany 35 1.6k 1.4× 512 0.8× 294 0.5× 147 0.3× 806 2.3× 70 3.8k
Koji Yasojima Canada 22 898 0.8× 1.1k 1.6× 439 0.7× 432 1.0× 581 1.7× 30 3.1k
John N. Snouwaert United States 22 1.3k 1.1× 375 0.6× 263 0.4× 327 0.7× 476 1.4× 40 2.8k
Robert Langenbach United States 25 946 0.8× 289 0.4× 241 0.4× 1.3k 2.8× 791 2.3× 38 3.5k
Ilka Nemere United States 41 1.6k 1.4× 479 0.7× 174 0.3× 128 0.3× 226 0.6× 109 4.6k

Countries citing papers authored by F. Nantel

Since Specialization
Citations

This map shows the geographic impact of F. Nantel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Nantel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Nantel more than expected).

Fields of papers citing papers by F. Nantel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Nantel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Nantel. The network helps show where F. Nantel may publish in the future.

Co-authorship network of co-authors of F. Nantel

This figure shows the co-authorship network connecting the top 25 collaborators of F. Nantel. A scholar is included among the top collaborators of F. Nantel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Nantel. F. Nantel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Coates, Laura C., Julio Ramírez, Dennis McGonagle, et al.. (2023). POS1540 EARLY SKIN AND EARLY ENTHESITIS RESPONSES IN PSORIATIC ARTHRITIS PATIENTS TREATED WITH GUSELKUMAB ASSOCIATE WITH LONG-TERM RESPONSE: POST HOC ANALYSIS THROUGH 2 YEARS OF A PHASE 3 STUDY. Annals of the Rheumatic Diseases. 82. 1137–1137. 1 indexed citations
3.
Nantel, F., et al.. (2022). Usage and Adherence of Seven Advanced Therapies with Differing Mechanisms of Action for Inflammatory Arthritis in Canada. Rheumatology and Therapy. 9(5). 1399–1420. 1 indexed citations
4.
5.
Takács, Péter, et al.. (2019). Persistence to subcutaneous biological agents in Hungarian patients treated for inflammatory arthritis. SHILAP Revista de lepidopterología.
6.
Takács, Péter, et al.. (2019). <p>Persistence to subcutaneous biological agents in Hungarian patients treated for inflammatory arthritis</p>. Patient Preference and Adherence. Volume 13. 157–163. 4 indexed citations
7.
Coates, Laura C., Proton Rahman, Eliofotisti Psaradellis, et al.. (2018). Validation of new potential targets for remission and low disease activity in psoriatic arthritis in patients treated with golimumab. Lara D. Veeken. 58(3). 522–526. 6 indexed citations
8.
Rahman, Proton, Michel Zummer, Louis Bessette, et al.. (2017). Real-world validation of the minimal disease activity index in psoriatic arthritis: an analysis from a prospective, observational, biological treatment registry. BMJ Open. 7(8). e016619–e016619. 22 indexed citations
9.
10.
Rahman, Proton, D. Choquette, W. Bensen, et al.. (2016). Biologic Treatment Registry Across Canada (BioTRAC): a multicentre, prospective, observational study of patients treated with infliximab for ankylosing spondylitis. BMJ Open. 6(4). e009661–e009661. 12 indexed citations
11.
Thorne, Carter, W. Bensen, D. Choquette, et al.. (2014). Effectiveness and Safety of Infliximab in Rheumatoid Arthritis: Analysis From a Canadian Multicenter Prospective Observational Registry. Arthritis Care & Research. 66(8). 1142–1151. 23 indexed citations
12.
Gabra, Bichoy H., Brigitte Guérin, Witold Neugebauer, et al.. (2004). Enhanced dermal and retinal vascular permeability in streptozotocin-induced type 1 diabetes in Wistar rats: blockade with a selective bradykinin B1 receptor antagonist. Regulatory Peptides. 124(1-3). 221–224. 37 indexed citations
13.
Maghni, Karim, et al.. (2004). Role of Airway Eosinophilia and Eosinophil Activation in Sephadex-induced Inflammation. Inflammation. 28(4). 195–206. 5 indexed citations
14.
Martin, James G., Masaru Suzuki, Karim Maghni, et al.. (2002). The Immunomodulatory Actions of Prostaglandin E2 on Allergic Airway Responses in the Rat. The Journal of Immunology. 169(7). 3963–3969. 67 indexed citations
15.
Lamontagne, Sonia, Pauline Luk, Eric S. Muise, et al.. (2001). Localization of phosphodiesterase-4 isoforms in the medulla and nodose ganglion of the squirrel monkey. Brain Research. 920(1-2). 84–96. 61 indexed citations
16.
Nantel, F., et al.. (1999). Immunolocalization of cyclooxygenase‐2 in the macula densa of human elderly. FEBS Letters. 457(3). 475–477. 98 indexed citations
17.
Nantel, F., et al.. (1999). Distribution and regulation of cyclooxygenase‐2 in carrageenan‐induced inflammation. British Journal of Pharmacology. 128(4). 853–859. 287 indexed citations
18.
Lamas, Mónica, Lucia Monaco, Emmanuel Zazopoulos, et al.. (1996). CREM: a master-switch in the transcriptional response to cAMP. Philosophical Transactions of the Royal Society B Biological Sciences. 351(1339). 561–567. 33 indexed citations
19.
20.
Buck, Stephen H., Scott L. Harbeson, Scott A. Shatzer, et al.. (1990). [Leu9ψ(CH2NH)Leu10]-Neurokinin A(4–10) (MDL 28, 564) distinguishes tissue tachykinin peptide NK2 receptors. Life Sciences. 47(10). PL37–PL41. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Motonao Nakamura Breakdown of academic impact, for papers by Takanobu Taniguchi Breakdown of academic impact, for papers by Kiyoshi Furuichi Breakdown of academic impact, for papers by David F. Woodward Breakdown of academic impact, for papers by Pascal Peraldi Breakdown of academic impact, for papers by Vasileia Ismini Alexaki Breakdown of academic impact, for papers by Koji Yasojima Breakdown of academic impact, for papers by John N. Snouwaert Breakdown of academic impact, for papers by Robert Langenbach Breakdown of academic impact, for papers by Ilka Nemere
Rankless by CCL
2026